Carmell Therapeutics Corp... (CTCX)
0.57
15.15%
At close: Jan 13, 2025, 3:14 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -15.45M | -9.05M | -6.48M |
| Depreciation & Amortization | 124.79K | 242.56K | 242.12K |
| Stock-Based Compensation | 667.68K | 636.37K | 246.80K |
| Other Working Capital | -2.97M | 1.28M | 872.37K |
| Other Non-Cash Items | 9.73M | 2.60M | 1.35M |
| Deferred Income Tax | n/a | -194.59K | 2.52M |
| Change in Working Capital | -3.42M | 2.34M | 952.69K |
| Operating Cash Flow | -8.35M | -3.43M | -1.18M |
| Capital Expenditures | -30.47K | -7.16K | -7.27K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -154.44M |
| Sales Maturities Of Investments | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | 154.44M |
| Investing Cash Flow | -30.47K | -7.16K | -7.27K |
| Debt Repayment | -3.20M | 2.75M | 1.12M |
| Common Stock Repurchased | n/a | -2.29K | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 14.32M | 807.98K | 67.82K |
| Financial Cash Flow | 11.16M | 3.55M | 1.20M |
| Net Cash Flow | 2.78M | 115.79K | 11.21K |
| Free Cash Flow | -8.38M | -3.44M | -1.18M |